LEADER 01946oam  2200637   450 
001 9910706192203321
005 20180619085150.0
035   $a(CKB)5470000002454501
035   $a(OCoLC)1001313463
035   $a(EXLCZ)995470000002454501
100   $a20170817d2016      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCounterfeit prescription pills containing fentanyls $ea global threat /$fprepared by the DEA Strategic Intelligence Section
210  1$a[Washington, D.C.] :$cDEA Strategic Intelligence Section,$d2016.
215   $a1 online resource (9 pages) $ccolor illustrations
225 1 $aDEA intelligence brief
300   $a"Unclassified."
300   $a"DEA-DCT-DIB-021-16."
300   $a"July 2016."
517   $aCounterfeit prescription pills containing fentanyls 
606   $aFentanyl
606   $aOpioid abuse
606   $aDrug adulteration
606   $aProduct counterfeiting
606   $aDrug traffic
606   $aDrug adulteration$2fast
606   $aDrug traffic$2fast
606   $aFentanyl$2fast
606   $aOpioid abuse$2fast
606   $aProduct counterfeiting$2fast
615  0$aFentanyl.
615  0$aOpioid abuse.
615  0$aDrug adulteration.
615  0$aProduct counterfeiting.
615  0$aDrug traffic.
615  7$aDrug adulteration.
615  7$aDrug traffic.
615  7$aFentanyl.
615  7$aOpioid abuse.
615  7$aProduct counterfeiting.
712 02$aUnited States.$bDrug Enforcement Administration.$bStrategic Intelligence Section,
801  0$bGPO
801  1$bGPO
801  2$bMERUC
801  2$bOCLCF
801  2$bOCLCA
801  2$bLWA
801  2$bGPO
906   $aBOOK
912   $a9910706192203321
996   $aCounterfeit prescription pills containing fentanyls$93442154
997   $aUNINA